Molecular Therapy, 2010 · DOI: 10.1038/mt.2010.133 · Published: October 1, 2010
This study investigates the role of Tenascin-C (TNC), a component of the extracellular matrix, in spinal cord injury recovery. The research compares recovery in TNC-deficient mice (TNC–/–) versus wild-type mice (TNC+/+) after spinal cord injury. The study found that TNC-deficient mice showed impaired locomotor recovery compared to wild-type mice, indicating TNC's importance in the recovery process. The impaired recovery was associated with reduced nerve excitability and reduced sprouting of certain nerve fibers. Introducing a specific component of TNC (fnD) through viral delivery improved locomotor recovery in wild-type mice. This suggests that TNC and its components have the potential to be used as a therapeutic approach for spinal cord injury.
TNC and its domains, particularly fnD, represent potential therapeutic targets for promoting regeneration after spinal cord injury.
Adeno-associated virus (AAV) vectors can be used to effectively deliver TNC-fnD to the injured spinal cord, enhancing recovery.
Combining TNC-based treatments with other regenerative molecules and agents may further improve outcomes after spinal cord injury.